Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Related structures:
AlphaFold database: Q4Q268
Term | Name | Level | Count |
---|---|---|---|
GO:0000731 | DNA synthesis involved in DNA repair | 6 | 2 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 12 |
GO:0006259 | DNA metabolic process | 4 | 12 |
GO:0006281 | DNA repair | 5 | 12 |
GO:0006301 | postreplication repair | 6 | 2 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 12 |
GO:0006807 | nitrogen compound metabolic process | 2 | 12 |
GO:0006950 | response to stress | 2 | 12 |
GO:0006974 | DNA damage response | 4 | 12 |
GO:0008152 | metabolic process | 1 | 12 |
GO:0009058 | biosynthetic process | 2 | 2 |
GO:0009059 | macromolecule biosynthetic process | 4 | 2 |
GO:0009987 | cellular process | 1 | 12 |
GO:0018130 | heterocycle biosynthetic process | 4 | 2 |
GO:0019438 | aromatic compound biosynthetic process | 4 | 2 |
GO:0019985 | translesion synthesis | 7 | 2 |
GO:0033554 | cellular response to stress | 3 | 12 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 12 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 4 | 2 |
GO:0042276 | error-prone translesion synthesis | 8 | 2 |
GO:0043170 | macromolecule metabolic process | 3 | 12 |
GO:0044237 | cellular metabolic process | 2 | 12 |
GO:0044238 | primary metabolic process | 2 | 12 |
GO:0044249 | cellular biosynthetic process | 3 | 2 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 12 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 4 | 2 |
GO:0046483 | heterocycle metabolic process | 3 | 12 |
GO:0050896 | response to stimulus | 1 | 12 |
GO:0051716 | cellular response to stimulus | 2 | 12 |
GO:0070987 | error-free translesion synthesis | 8 | 2 |
GO:0071704 | organic substance metabolic process | 2 | 12 |
GO:0071897 | DNA biosynthetic process | 5 | 2 |
GO:0090304 | nucleic acid metabolic process | 4 | 12 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 12 |
GO:1901362 | organic cyclic compound biosynthetic process | 4 | 2 |
GO:1901576 | organic substance biosynthetic process | 3 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 12 |
GO:0003677 | DNA binding | 4 | 12 |
GO:0003684 | damaged DNA binding | 5 | 12 |
GO:0003824 | catalytic activity | 1 | 3 |
GO:0003887 | DNA-directed DNA polymerase activity | 5 | 3 |
GO:0005488 | binding | 1 | 12 |
GO:0016740 | transferase activity | 2 | 3 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 3 | 3 |
GO:0016779 | nucleotidyltransferase activity | 4 | 3 |
GO:0017125 | deoxycytidyl transferase activity | 5 | 2 |
GO:0034061 | DNA polymerase activity | 4 | 3 |
GO:0097159 | organic cyclic compound binding | 2 | 12 |
GO:0140097 | catalytic activity, acting on DNA | 3 | 3 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 3 |
GO:1901363 | heterocyclic compound binding | 2 | 12 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 263 | 267 | PF00656 | 0.581 |
CLV_C14_Caspase3-7 | 535 | 539 | PF00656 | 0.565 |
CLV_NRD_NRD_1 | 186 | 188 | PF00675 | 0.303 |
CLV_NRD_NRD_1 | 359 | 361 | PF00675 | 0.298 |
CLV_NRD_NRD_1 | 417 | 419 | PF00675 | 0.290 |
CLV_PCSK_KEX2_1 | 186 | 188 | PF00082 | 0.305 |
CLV_PCSK_KEX2_1 | 279 | 281 | PF00082 | 0.457 |
CLV_PCSK_KEX2_1 | 289 | 291 | PF00082 | 0.612 |
CLV_PCSK_KEX2_1 | 321 | 323 | PF00082 | 0.524 |
CLV_PCSK_KEX2_1 | 359 | 361 | PF00082 | 0.297 |
CLV_PCSK_KEX2_1 | 505 | 507 | PF00082 | 0.607 |
CLV_PCSK_PC1ET2_1 | 279 | 281 | PF00082 | 0.433 |
CLV_PCSK_PC1ET2_1 | 289 | 291 | PF00082 | 0.614 |
CLV_PCSK_PC1ET2_1 | 321 | 323 | PF00082 | 0.548 |
CLV_PCSK_PC1ET2_1 | 505 | 507 | PF00082 | 0.595 |
CLV_PCSK_PC7_1 | 285 | 291 | PF00082 | 0.458 |
CLV_PCSK_PC7_1 | 317 | 323 | PF00082 | 0.653 |
CLV_PCSK_SKI1_1 | 137 | 141 | PF00082 | 0.274 |
CLV_PCSK_SKI1_1 | 187 | 191 | PF00082 | 0.339 |
CLV_PCSK_SKI1_1 | 209 | 213 | PF00082 | 0.249 |
CLV_PCSK_SKI1_1 | 280 | 284 | PF00082 | 0.428 |
CLV_PCSK_SKI1_1 | 305 | 309 | PF00082 | 0.418 |
CLV_PCSK_SKI1_1 | 348 | 352 | PF00082 | 0.265 |
CLV_PCSK_SKI1_1 | 468 | 472 | PF00082 | 0.290 |
CLV_PCSK_SKI1_1 | 582 | 586 | PF00082 | 0.423 |
DEG_APCC_DBOX_1 | 279 | 287 | PF00400 | 0.438 |
DEG_APCC_DBOX_1 | 347 | 355 | PF00400 | 0.462 |
DEG_APCC_DBOX_1 | 581 | 589 | PF00400 | 0.494 |
DOC_CYCLIN_RxL_1 | 184 | 193 | PF00134 | 0.504 |
DOC_CYCLIN_RxL_1 | 345 | 353 | PF00134 | 0.459 |
DOC_CYCLIN_yCln2_LP_2 | 612 | 618 | PF00134 | 0.398 |
DOC_MAPK_DCC_7 | 418 | 426 | PF00069 | 0.504 |
DOC_MAPK_gen_1 | 119 | 128 | PF00069 | 0.539 |
DOC_MAPK_gen_1 | 137 | 147 | PF00069 | 0.542 |
DOC_MAPK_gen_1 | 214 | 222 | PF00069 | 0.489 |
DOC_MAPK_gen_1 | 389 | 397 | PF00069 | 0.533 |
DOC_MAPK_gen_1 | 418 | 426 | PF00069 | 0.589 |
DOC_MAPK_gen_1 | 505 | 515 | PF00069 | 0.689 |
DOC_MAPK_MEF2A_6 | 389 | 397 | PF00069 | 0.532 |
DOC_MAPK_MEF2A_6 | 57 | 64 | PF00069 | 0.400 |
DOC_PP1_RVXF_1 | 21 | 27 | PF00149 | 0.349 |
DOC_PP2B_LxvP_1 | 612 | 615 | PF13499 | 0.419 |
DOC_USP7_MATH_1 | 243 | 247 | PF00917 | 0.490 |
DOC_USP7_MATH_1 | 455 | 459 | PF00917 | 0.453 |
DOC_USP7_MATH_1 | 532 | 536 | PF00917 | 0.580 |
DOC_USP7_UBL2_3 | 381 | 385 | PF12436 | 0.437 |
DOC_WW_Pin1_4 | 440 | 445 | PF00397 | 0.379 |
DOC_WW_Pin1_4 | 516 | 521 | PF00397 | 0.679 |
LIG_14-3-3_CanoR_1 | 137 | 143 | PF00244 | 0.539 |
LIG_14-3-3_CanoR_1 | 209 | 217 | PF00244 | 0.472 |
LIG_14-3-3_CanoR_1 | 369 | 373 | PF00244 | 0.495 |
LIG_14-3-3_CanoR_1 | 468 | 473 | PF00244 | 0.526 |
LIG_14-3-3_CanoR_1 | 506 | 515 | PF00244 | 0.652 |
LIG_Actin_WH2_2 | 225 | 240 | PF00022 | 0.499 |
LIG_Actin_WH2_2 | 343 | 361 | PF00022 | 0.527 |
LIG_Actin_WH2_2 | 444 | 462 | PF00022 | 0.512 |
LIG_APCC_ABBA_1 | 178 | 183 | PF00400 | 0.388 |
LIG_APCC_ABBAyCdc20_2 | 57 | 63 | PF00400 | 0.448 |
LIG_BIR_III_4 | 266 | 270 | PF00653 | 0.436 |
LIG_CaM_IQ_9 | 15 | 31 | PF13499 | 0.353 |
LIG_CaM_IQ_9 | 272 | 287 | PF13499 | 0.364 |
LIG_deltaCOP1_diTrp_1 | 40 | 48 | PF00928 | 0.445 |
LIG_FHA_1 | 359 | 365 | PF00498 | 0.457 |
LIG_FHA_1 | 451 | 457 | PF00498 | 0.450 |
LIG_FHA_1 | 507 | 513 | PF00498 | 0.533 |
LIG_FHA_1 | 539 | 545 | PF00498 | 0.567 |
LIG_FHA_1 | 81 | 87 | PF00498 | 0.491 |
LIG_FHA_2 | 30 | 36 | PF00498 | 0.492 |
LIG_FHA_2 | 369 | 375 | PF00498 | 0.458 |
LIG_FHA_2 | 512 | 518 | PF00498 | 0.777 |
LIG_GBD_Chelix_1 | 364 | 372 | PF00786 | 0.339 |
LIG_LIR_Apic_2 | 589 | 594 | PF02991 | 0.456 |
LIG_LIR_Gen_1 | 141 | 151 | PF02991 | 0.457 |
LIG_LIR_Gen_1 | 172 | 181 | PF02991 | 0.488 |
LIG_LIR_Gen_1 | 293 | 303 | PF02991 | 0.429 |
LIG_LIR_Gen_1 | 58 | 67 | PF02991 | 0.311 |
LIG_LIR_Gen_1 | 600 | 608 | PF02991 | 0.506 |
LIG_LIR_Gen_1 | 77 | 86 | PF02991 | 0.362 |
LIG_LIR_Nem_3 | 141 | 146 | PF02991 | 0.504 |
LIG_LIR_Nem_3 | 172 | 178 | PF02991 | 0.504 |
LIG_LIR_Nem_3 | 293 | 299 | PF02991 | 0.363 |
LIG_LIR_Nem_3 | 341 | 347 | PF02991 | 0.478 |
LIG_LIR_Nem_3 | 541 | 546 | PF02991 | 0.515 |
LIG_LIR_Nem_3 | 573 | 577 | PF02991 | 0.453 |
LIG_LIR_Nem_3 | 58 | 62 | PF02991 | 0.335 |
LIG_LIR_Nem_3 | 600 | 604 | PF02991 | 0.411 |
LIG_LIR_Nem_3 | 65 | 71 | PF02991 | 0.414 |
LIG_LIR_Nem_3 | 77 | 81 | PF02991 | 0.362 |
LIG_LYPXL_yS_3 | 574 | 577 | PF13949 | 0.484 |
LIG_MAD2 | 305 | 313 | PF02301 | 0.532 |
LIG_PDZ_Class_3 | 614 | 619 | PF00595 | 0.522 |
LIG_Pex14_2 | 26 | 30 | PF04695 | 0.350 |
LIG_Pex14_2 | 38 | 42 | PF04695 | 0.376 |
LIG_REV1ctd_RIR_1 | 499 | 506 | PF16727 | 0.689 |
LIG_SH2_CRK | 143 | 147 | PF00017 | 0.437 |
LIG_SH2_CRK | 175 | 179 | PF00017 | 0.539 |
LIG_SH2_CRK | 296 | 300 | PF00017 | 0.424 |
LIG_SH2_GRB2like | 114 | 117 | PF00017 | 0.448 |
LIG_SH2_SRC | 114 | 117 | PF00017 | 0.448 |
LIG_SH2_SRC | 143 | 146 | PF00017 | 0.457 |
LIG_SH2_SRC | 239 | 242 | PF00017 | 0.465 |
LIG_SH2_STAP1 | 130 | 134 | PF00017 | 0.527 |
LIG_SH2_STAT5 | 102 | 105 | PF00017 | 0.437 |
LIG_SH2_STAT5 | 114 | 117 | PF00017 | 0.437 |
LIG_SH2_STAT5 | 239 | 242 | PF00017 | 0.454 |
LIG_SH2_STAT5 | 25 | 28 | PF00017 | 0.538 |
LIG_SH2_STAT5 | 543 | 546 | PF00017 | 0.409 |
LIG_SH2_STAT5 | 580 | 583 | PF00017 | 0.394 |
LIG_SH3_3 | 374 | 380 | PF00018 | 0.437 |
LIG_SH3_3 | 392 | 398 | PF00018 | 0.437 |
LIG_SH3_3 | 40 | 46 | PF00018 | 0.316 |
LIG_SH3_3 | 512 | 518 | PF00018 | 0.618 |
LIG_SH3_3 | 525 | 531 | PF00018 | 0.643 |
LIG_SUMO_SIM_anti_2 | 511 | 517 | PF11976 | 0.669 |
LIG_SUMO_SIM_par_1 | 422 | 428 | PF11976 | 0.526 |
LIG_SUMO_SIM_par_1 | 452 | 458 | PF11976 | 0.435 |
LIG_SUMO_SIM_par_1 | 511 | 517 | PF11976 | 0.700 |
LIG_TRFH_1 | 147 | 151 | PF08558 | 0.445 |
LIG_TYR_ITIM | 572 | 577 | PF00017 | 0.439 |
LIG_TYR_ITSM | 139 | 146 | PF00017 | 0.539 |
LIG_TYR_ITSM | 292 | 299 | PF00017 | 0.420 |
LIG_WRC_WIRS_1 | 604 | 609 | PF05994 | 0.451 |
MOD_CK1_1 | 95 | 101 | PF00069 | 0.437 |
MOD_CK2_1 | 114 | 120 | PF00069 | 0.526 |
MOD_CK2_1 | 159 | 165 | PF00069 | 0.448 |
MOD_CK2_1 | 243 | 249 | PF00069 | 0.567 |
MOD_CK2_1 | 29 | 35 | PF00069 | 0.491 |
MOD_CK2_1 | 368 | 374 | PF00069 | 0.445 |
MOD_CK2_1 | 429 | 435 | PF00069 | 0.472 |
MOD_CK2_1 | 440 | 446 | PF00069 | 0.492 |
MOD_CK2_1 | 511 | 517 | PF00069 | 0.722 |
MOD_Cter_Amidation | 287 | 290 | PF01082 | 0.443 |
MOD_Cter_Amidation | 319 | 322 | PF01082 | 0.535 |
MOD_GlcNHglycan | 116 | 119 | PF01048 | 0.291 |
MOD_GlcNHglycan | 190 | 193 | PF01048 | 0.300 |
MOD_GlcNHglycan | 490 | 493 | PF01048 | 0.705 |
MOD_GlcNHglycan | 566 | 569 | PF01048 | 0.514 |
MOD_GSK3_1 | 425 | 432 | PF00069 | 0.515 |
MOD_GSK3_1 | 468 | 475 | PF00069 | 0.482 |
MOD_GSK3_1 | 603 | 610 | PF00069 | 0.405 |
MOD_GSK3_1 | 92 | 99 | PF00069 | 0.457 |
MOD_NEK2_1 | 181 | 186 | PF00069 | 0.470 |
MOD_NEK2_1 | 190 | 195 | PF00069 | 0.430 |
MOD_NEK2_1 | 368 | 373 | PF00069 | 0.447 |
MOD_NEK2_1 | 4 | 9 | PF00069 | 0.604 |
MOD_NEK2_1 | 425 | 430 | PF00069 | 0.500 |
MOD_NEK2_1 | 607 | 612 | PF00069 | 0.484 |
MOD_NEK2_1 | 67 | 72 | PF00069 | 0.448 |
MOD_NEK2_2 | 455 | 460 | PF00069 | 0.488 |
MOD_NEK2_2 | 524 | 529 | PF00069 | 0.598 |
MOD_PIKK_1 | 380 | 386 | PF00454 | 0.462 |
MOD_PIKK_1 | 506 | 512 | PF00454 | 0.570 |
MOD_PKA_2 | 358 | 364 | PF00069 | 0.472 |
MOD_PKA_2 | 368 | 374 | PF00069 | 0.411 |
MOD_PKA_2 | 488 | 494 | PF00069 | 0.646 |
MOD_Plk_2-3 | 159 | 165 | PF00069 | 0.450 |
MOD_Plk_2-3 | 511 | 517 | PF00069 | 0.669 |
MOD_Plk_4 | 138 | 144 | PF00069 | 0.504 |
MOD_Plk_4 | 291 | 297 | PF00069 | 0.515 |
MOD_Plk_4 | 368 | 374 | PF00069 | 0.432 |
MOD_Plk_4 | 511 | 517 | PF00069 | 0.712 |
MOD_Plk_4 | 538 | 544 | PF00069 | 0.454 |
MOD_ProDKin_1 | 440 | 446 | PF00069 | 0.379 |
MOD_ProDKin_1 | 516 | 522 | PF00069 | 0.680 |
MOD_SUMO_for_1 | 278 | 281 | PF00179 | 0.490 |
MOD_SUMO_for_1 | 74 | 77 | PF00179 | 0.462 |
TRG_DiLeu_BaLyEn_6 | 420 | 425 | PF01217 | 0.504 |
TRG_ENDOCYTIC_2 | 143 | 146 | PF00928 | 0.437 |
TRG_ENDOCYTIC_2 | 175 | 178 | PF00928 | 0.504 |
TRG_ENDOCYTIC_2 | 296 | 299 | PF00928 | 0.421 |
TRG_ENDOCYTIC_2 | 574 | 577 | PF00928 | 0.409 |
TRG_ENDOCYTIC_2 | 78 | 81 | PF00928 | 0.591 |
TRG_ER_diArg_1 | 185 | 187 | PF00400 | 0.488 |
TRG_ER_diArg_1 | 358 | 360 | PF00400 | 0.520 |
TRG_ER_diArg_1 | 487 | 490 | PF00400 | 0.738 |
TRG_NES_CRM1_1 | 63 | 77 | PF08389 | 0.437 |
TRG_NLS_MonoCore_2 | 504 | 509 | PF00514 | 0.655 |
TRG_Pf-PMV_PEXEL_1 | 253 | 257 | PF00026 | 0.536 |
TRG_Pf-PMV_PEXEL_1 | 348 | 352 | PF00026 | 0.268 |
TRG_Pf-PMV_PEXEL_1 | 429 | 433 | PF00026 | 0.278 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PA19 | Leptomonas seymouri | 70% | 100% |
A0A0S4JRX6 | Bodo saltans | 42% | 87% |
A0A1X0P8Q5 | Trypanosomatidae | 50% | 98% |
A0A3S7XA64 | Leishmania donovani | 95% | 100% |
A0A422NAZ8 | Trypanosoma rangeli | 49% | 100% |
A4HNL7 | Leishmania braziliensis | 82% | 99% |
A4ICX7 | Leishmania infantum | 94% | 100% |
D0A2H2 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 49% | 100% |
E9ASC8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 93% | 100% |
V5BV86 | Trypanosoma cruzi | 49% | 100% |